Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Publication
, Journal Article
Fekrat, S; Ehlers JP; Decroos FC; Stinnett S
Published in: Retina: the Journal of Retinal and Vitreous Diseases
2011
Duke Scholars
Published In
Retina: the Journal of Retinal and Vitreous Diseases
Publication Date
2011
Volume
31
Issue
9
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 1113 Opthalmology and Optometry
Citation
APA
Chicago
ICMJE
MLA
NLM
Fekrat, S., Ehlers JP, ., Decroos FC, ., & Stinnett S, . (2011). Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina: The Journal of Retinal and Vitreous Diseases, 31(9).
Fekrat, S., S. Ehlers JP, S. Decroos FC, and S. Stinnett S. “Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.” Retina: The Journal of Retinal and Vitreous Diseases 31, no. 9 (2011).
Fekrat S, Ehlers JP, Decroos FC, Stinnett S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina: the Journal of Retinal and Vitreous Diseases. 2011;31(9).
Fekrat, S., et al. “Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.” Retina: The Journal of Retinal and Vitreous Diseases, vol. 31, no. 9, 2011.
Fekrat S, Ehlers JP, Decroos FC, Stinnett S. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina: the Journal of Retinal and Vitreous Diseases. 2011;31(9).
Published In
Retina: the Journal of Retinal and Vitreous Diseases
Publication Date
2011
Volume
31
Issue
9
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 1113 Opthalmology and Optometry